Network Pharmacology Combined with Proteomics Reveals That 3‑Acetyl-11-keto-β-boswellic Acid Inhibits the Progression of Prostate Cancer by Regulating the IL-17 Signaling Pathway
Saved in:
| Main Authors: | Bo Zou, Qizhi Liu, Yan Long, Xinjun Dai, Xuefei Tian, Qing Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2025-05-01
|
| Series: | ACS Omega |
| Online Access: | https://doi.org/10.1021/acsomega.5c01683 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acetyl-11-keto-β-boswellic acid alleviates hepatic metabolic dysfunction by inhibiting MGLL activity
by: Kai Luan, et al.
Published: (2025-05-01) -
Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
by: Sefora Conti, et al.
Published: (2018-01-01) -
Acetyl-11-keto-β-boswellic acid restrains the progression of synovitis in osteoarthritis via the Nrf2/HO-1 pathway
by: Zhou Jing, et al.
Published: (2024-07-01) -
Comparative Study of Pectin and Kappa-Carrageenan-Based Films Loaded With Boswellic Acid and Acetyl-11-Keto-Beta-Boswellic Acid for Active Packaging
by: Yasir Abbas Shah, et al.
Published: (2025-01-01) -
Effects of 1<i>H</i>-1,2,3-Triazole Derivatives of 3-<i>O</i>-Acetyl-11-Keto-Beta-Boswellic Acid from <i>Boswellia sacra</i> Resin on T-Cell Proliferation and Activation
by: Abdo Meyiah, et al.
Published: (2024-12-01)